Treatments

Recently, you may have heard about a study that has revealed that sunscreen (or more accurately certain compounds in sunscreen) can prevent the development of disease in a mouse model of multiple sclerosis. ...

We have been discussing lifestyle factors, such as diet and exercise, a lot recently on MStranslate.  This has been presented both in terms of the reported benefits of these approaches from anecdotal evidence...

Across the last few weeks, the MStranslate Facebook page has placed a large focus on lifestyle modifications and how they can be used to help manage multiple sclerosis. As well as gauging how members of the MS...

“Doing the little things can make a big difference” - Yogi Berra We constantly marvel at the hard-work, dedication and perseverance of multiple sclerosis researchers around the world.  It is through...

Firstly, we would like to thank everyone who contributed to last week's poll gauging the community's interest in access to medicinal cannabis for the management of multiple sclerosis.  Considering the...

On Tuesday, Innate Immunotherapeutics released a report outlining the first set of results from their Phase 2b trial on the use of their compound, MIS416, in people with secondary progressive multiple...

Recently, I’ve had the pleasure of talking to a number of different local multiple sclerosis support groups about multiple sclerosis (MS) and MS research.  These events generally involve me giving a small...

Research Summary: Evaluating the safety of β-interferons in MS Research from the University of British Columbia has looked at the long-term health effects of interferon-beta treatment in people with...

There has been a lot of media attention recently on a trial testing statins as a treatment for multiple sclerosis (MS).  The study is being led by University College London and will involve over 1100 people...

It has been reported this week that daclizumab (marketed as Zinbryta) has been added to the Pharmaceutical Benefits Scheme (PBS) in Australia.  Considering this, we thought it appropriate to provide some more...